5.32 USD
▼+0.33-2.56%
盘后 5.54 +1.46%
2026-08-03
市值
$528.29M
市盈率
—
EPS
-2.00
股息率
—
52 周区间
4.91 – 18.00
成交量
1.93M
Beta
0.97
目标价
26.75
52W 低 4.9152W 高 18.00
价格走势
公司简介
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.